Brief: Somnomed Sees FY25 EBITDA Of More Than A$5 Million

SomnoMed

28/08/2024 02:25

Aug 28 (Reuters) - Somnomed Ltd  SOM.AX :
    * SEES FY25 EBITDA OF MORE THAN A$5 MILLION
    * SEES FY25 CAPEX OF BETWEEN A$3 MILLION AND A$4 MILLION
    * SEES REVENUE OF APPROXIMATELY A$100 MILLION IN FY25
    * TRADING IN FIRST 8 WEEKS OF FY25 HAS SEEN REVENUE UP 20%
YEAR-ON-YEAR


Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))